Neurotoxic Mechanisms of Reactive Nitrogen Intermediates
活性氮中间体的神经毒性机制
基本信息
- 批准号:7418655
- 负责人:
- 金额:$ 27.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-04-15 至 2010-03-31
- 项目状态:已结题
- 来源:
- 关键词:2-tyrosine3-nitropropionic acid3-nitrotyrosineATP Synthesis PathwayAmino AcidsAngiotensin IIAnimalsApoptosisApoptoticArchitectureAromatic-L-Amino-Acid DecarboxylasesBehavioralBiochemicalBiochemistryBiological ModelsBiologyBlood VesselsBronchoalveolar Lavage FluidCarboxy-LyasesCell LineCell modelCellsCessation of lifeChemistryConditionCorpus striatum structureDataDetectionDinitrophenolsDiseaseDisruptionDocumentationDopaDopamineEnzymesEventFamilyFunctional disorderFundingHalf-LifeHumanIn VitroInjection of therapeutic agentInvestigationKnowledgeLeadLinkLipidsMediator of activation proteinMetabolic PathwayMetabolismMethodologyMicrotubulesMitochondriaMitochondrial Electron Transport Complex IIModelingMolecularMolecular TargetMotor NeuronsNatureNerve DegenerationNeurodegenerative DisordersNeuronal DysfunctionNeuronal InjuryNeuronsNitratesNitric OxideNitrogenNitrogen OxidesOxidantsOxidative PhosphorylationOxidative StressOxidopamineParkinson DiseaseParkinsonian DisordersPathway interactionsPermeabilityPlasmaPositioning AttributeProductionProteinsRattusReactive Nitrogen SpeciesRegulatory PathwayReportingResearch PersonnelRespirationRodentRoleTeratocarcinomaTestingTimeToxic effectTubulinTyrosineTyrosine 3-MonooxygenaseTyrosine Metabolism PathwayUncoupling AgentsUpper armWorkalpha synucleinbasebeta Tubulindopaminergic neuronexperiencehemodynamicsin vivoinhibitor/antagonistinjuredmembrane polaritymitochondrial membranemulticatalytic endopeptidase complexneurotoxicneurotoxicitynitratenitrationnovelpressurepreventprogramsprotein aggregateprotein aggregationprotein degradationresearch studyresponsesoundsynucleintyrosyltubulin ligasevascular endothelial dysfunction
项目摘要
DESCRIPTION (provided by applicant): The detection of oxidized proteins, lipids and DNA/RNA in human as well as animal and cellular models of neurodegenerative diseases has been documented. In the last decade additional chemistry based on the formation of reactive nitrogen oxides, byproducts of nitric oxide reactivity have been also documented by the detection of tyrosine-nitrated proteins mostly in the inclusions that characterize Parkinson's and other related diseases. Recent data has also indicated that reactive nitrogen oxides convert the free amino acid tyrosine to 3-nitrotyrosine. This unusual amino acid can be also formed in the CNS following the proteolytic degradation of nitrated proteins. Tyrosine is an important amino acid in the CNS since it serves as the building block for the formation of dopamine. We hypothesize that 3-nitrotyrosine interferes primarily with dopamine formation and tyrosine metabolism. Support for this hypothesis is derived from the sound documentation that 3-nitrotyrosine injected into rodent striatum selectively injures dopaminergic neurons. Another unrecognized feature of 3-nitrotyrosine may be the interference with mitochondrial respiration leading to the decline in ATP synthesis and additional production of reactive species. Preliminary data have also indicated a specific 3- nitrotyrosine-dependent disruption of microtubule assembly leading to the formation of soluble and insoluble protein aggregates. To test the critical aspects of these hypotheses we propose to evaluate the following: 1) determine if 3-nitrotyrosine interferes with the production, metabolism and biology of dopamine and tyrosine, 2) evaluate if 3-nitrotyroinse interferes with mitochondrial respiration and function and 3) examine if the formation of alpha/beta-tubulin aggregates resulting from the specific incorporation of 3-nitroyrosine into a-tubulin serves as a building block for the aggregation and/or fibrilization of alpha-synuclein. An array of biochemical, pharmacological, and molecular approaches that are already in place will be employed to perform the proposed experiments. The proposed experiments will evaluate the critical role of the endogenously generated unusual amino acid, 3-nitrotyrosine, as a central mediator responsible for alterations in fundamental regulatory pathways in dopamine metabolism, oxidative phosphorylation, and protein aggregation, which constitute well-recognized molecular targets responsible for neuronal injury and death in Parkinson's disease and related disorders. Overall a novel and previously unrecognized biological chemistry resulting from the formation of a modified amino acid, 3-nitrotyrosine, will be investigated in order to uncover multifaceted but potentially interrelated pathways that promote neuronal dysfunction in neurodegenerative disorders.
描述(由申请人提供):人类以及神经退行性疾病的动物和细胞模型中氧化蛋白质、脂质和 DNA/RNA 的检测已被记录。在过去的十年中,基于活性氮氧化物形成的附加化学,一氧化氮反应性的副产物也已通过检测酪氨酸硝化蛋白质(主要存在于帕金森病和其他相关疾病的内含物中)来记录。最近的数据还表明,活性氮氧化物将游离氨基酸酪氨酸转化为 3-硝基酪氨酸。这种不寻常的氨基酸也可以在硝化蛋白质的蛋白水解降解后在中枢神经系统中形成。酪氨酸是中枢神经系统中的重要氨基酸,因为它是形成多巴胺的基本成分。我们假设 3-硝基酪氨酸主要干扰多巴胺形成和酪氨酸代谢。这一假设的支持来自于将 3-硝基酪氨酸注射到啮齿动物纹状体中选择性损伤多巴胺能神经元的可靠文献。 3-硝基酪氨酸的另一个未被认识的特征可能是干扰线粒体呼吸,导致 ATP 合成下降和活性物质的额外产生。初步数据还表明,微管组装的特定3-硝基酪氨酸依赖性破坏导致可溶性和不溶性蛋白质聚集体的形成。为了测试这些假设的关键方面,我们建议评估以下内容:1) 确定 3-硝基酪氨酸是否干扰多巴胺和酪氨酸的产生、代谢和生物学,2) 评估 3-硝基酪氨酸是否干扰线粒体呼吸和功能,3) )检查 3-硝基酪氨酸特异性掺入 α-微管蛋白所形成的 α/β-微管蛋白聚集体是否可作为构建模块α-突触核蛋白的聚集和/或纤维化。将采用一系列已经到位的生化、药理学和分子方法来进行拟议的实验。拟议的实验将评估内源产生的不寻常氨基酸 3-硝基酪氨酸的关键作用,它作为负责改变多巴胺代谢、氧化磷酸化和蛋白质聚集的基本调节途径的中心介质,这些途径构成了公认的负责多巴胺代谢、氧化磷酸化和蛋白质聚集的分子靶标。用于帕金森病和相关疾病的神经元损伤和死亡。总体而言,我们将研究由修饰氨基酸 3-硝基酪氨酸形成而产生的一种新颖且以前未被认识的生物化学,以揭示促进神经退行性疾病中神经元功能障碍的多方面但可能相互关联的途径。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HARRY ISCHIROPOULOS其他文献
HARRY ISCHIROPOULOS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HARRY ISCHIROPOULOS', 18)}}的其他基金
Hybrid Triple Quadrupole Mass Spectrometer for Quantitative Mass Spectrometric Ap
用于定量质谱应用的混合三重四极杆质谱仪
- 批准号:
7794609 - 财政年份:2010
- 资助金额:
$ 27.33万 - 项目类别:
Oxidative Modifications of Proteins and Fibrinogen in Atherosclerosis
动脉粥样硬化中蛋白质和纤维蛋白原的氧化修饰
- 批准号:
6744265 - 财政年份:2003
- 资助金额:
$ 27.33万 - 项目类别:
CONFERENCE ON THE CHEMISTRY AND BIOLOGY OF PEROXYNITRITE
过氧亚硝酸盐化学和生物学会议
- 批准号:
2885038 - 财政年份:1999
- 资助金额:
$ 27.33万 - 项目类别:
相似国自然基金
霉变甘蔗病原菌节菱孢菌株产毒能力评价及产毒调节机理研究
- 批准号:31860014
- 批准年份:2018
- 资助金额:40.0 万元
- 项目类别:地区科学基金项目
3-硝基丙酸预处理保护多巴胺神经元机制的研究
- 批准号:30170334
- 批准年份:2001
- 资助金额:16.0 万元
- 项目类别:面上项目
变质甘蔗中毒毒素3-硝基丙酸的神经毒理学研究
- 批准号:39170659
- 批准年份:1991
- 资助金额:3.0 万元
- 项目类别:面上项目
相似海外基金
Mechanisms of delayed degeneration of hair cells and spiral ganglion cell
毛细胞和螺旋神经节细胞延迟变性的机制
- 批准号:
26462572 - 财政年份:2014
- 资助金额:
$ 27.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mitochondrial dynamics and metabolomic biomarkers in neurodegenerative disorders
神经退行性疾病中的线粒体动力学和代谢组生物标志物
- 批准号:
8691816 - 财政年份:2011
- 资助金额:
$ 27.33万 - 项目类别:
Mitochondrial dynamics and metabolomic biomarkers in neurodegenerative disorders
神经退行性疾病中的线粒体动力学和代谢组生物标志物
- 批准号:
8216043 - 财政年份:2011
- 资助金额:
$ 27.33万 - 项目类别:
Mitochondrial dynamics and metabolomic biomarkers in neurodegenerative disorders
神经退行性疾病中的线粒体动力学和代谢组生物标志物
- 批准号:
8917662 - 财政年份:2011
- 资助金额:
$ 27.33万 - 项目类别: